Covid Vaccines May Only Stop Covid Symptoms: Yuen

"); jQuery("#212 h3").html("

Related News Programmes

"); });

2020-12-25 HKT 13:52

Share this story

facebook

  • Yuen Kwok-yung and his research team analyse the three coronavirus vaccines procured by the government in a newspaper article. Photo: RTHK

    Yuen Kwok-yung and his research team analyse the three coronavirus vaccines procured by the government in a newspaper article. Photo: RTHK

Government adviser Yuen Kwok-yung said on Friday that the three types of coronavirus vaccines procured by the government may not be able to help Hong Kong avoid asymptomatic infections, but he stressed there is still an urgent need for everyone to get inoculated.

The University of Hong Kong microbiologist explained that early lab tests showed the vaccines could trigger the production of neutralizing antibodies to prevent a person from developing symptoms or complications after being infected, but they could not stop a person from releasing the virus and infecting others.

Still, Yuen highlighted that efforts to help Hong Kong develop herd immunity should get underway as soon as possible.

"There is an imminent need to launch a universal innoculation programme," Yuen wrote with his research team in the Chinese-language Ming Pao newspaper.

Yuen, who is a member of the government's independent advisory panel on Covid-19 vaccines, also suggested that vaccines produced by Fosun-BioNtech and the mainland's Sinovac could be better options to be introduced in Hong Kong first.

He noted that trial results out so far for the Sinovac vaccine showed that it carries the fewest side-effects, but is expected to offer a shorter protection period.

But he stressed that the government must wait for Sinovac's late-stage trial results, which will not be released until next month after a delay, and conduct a thorough analysis before deciding to use its vaccine.

As for the vaccine developed by Fosun and BioNTech, Yuen said clinical trials showed that it is relatively safe and also offers good protection.

But he said it is necessary to observe the third option by Oxford University and AstraZeneca for a longer period of time for any side effects, noting that two people who earlier received the jabs had developed a neurological disorder.

Yuen urged the government to boost public confidence in inoculating against the coronavirus by being transparent.

"The inoculation scheme must aim to be quick, widespread, open and with choices for people to pick," he said.

RECENT NEWS

Tencent Officially Launches T1 Reasoning Model In Chinas Competitive AI Landscape

Tencent has officially unveiled its T1 reasoning model, marking a significant step forward in the increasingly competit... Read more

Ping An Insurance Achieves A 47.8% Rise In 2024 Net Profit

Ping An Insurance (Group) Company of China, Ltd. (Ping An) announced on 19 March 2025 its financial results for the yea... Read more

HashKey Capital Secures Type 1 Licence From SFC, Grows Crypto Services In HK

On 18 March 2025, HashKey Capital received a Type 1 licence from the Hong Kong Securities and Futures Commission (SFC),... Read more

Ping An P&C And FAW Hongqi Launch Hongqi Intelligent Driving Protection Services

Ping An Property & Casualty Insurance Company of China (Ping An P&C), a subsidiary of Ping An Insurance, has pa... Read more

HKSTP European Innovation Mixer Tour Nurtures Global Ties For Hong Kong

The Hong Kong Science and Technology Parks Corporation (HKSTP), led by CEO Albert Wong, conducted the HKSTP European In... Read more

The Full List Of Fintech Unicorns In Hong Kong (2025)

Hong Kong’s fintech landscape has evolved into a dynamic force in Asia, driven by regulatory innovation, technologica... Read more